Skip to content

Based on DIA Proteomics: Efficacy Evaluation and Prognosis Prediction of Acupuncture Intervention for Migraine

Based on DIA Proteomics: Efficacy Evaluation and Prognosis Prediction of Acupuncture Intervention for Migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000359
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Acupuncture group:Conventional Therapy+ "Tongshentongluo" acupuncture
sham acupuncture group:Conventional Therapy+ Non-Acupoint Superficial acupuncture

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria for migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) of the International Headache Society (IHS), 2018. 2.Having experienced at least one migraine attack within the past week. 3.Not having received any preventive acupuncture or medication for migraine in the past week. 4.Aged between 18 and 75 years, right-handed, and of either sex. 5.Voluntarily providing signed informed consent and able to adhere to the treatment regimen. 6.Not having participated in any other interventional clinical trial within the past month.

Exclusion criteria

Exclusion criteria: 1.Patients with severe systemic diseases that prevent participation and cooperation in the trial. 2.Patients unable to cooperate with physical examinations or neuropsychological assessments due to hearing or visual impairments, aphasia, cognitive disorders, etc. 3.Patients comorbid with psychiatric or mental disorders. 4.Patients with poor compliance or limited financial resources, who are unable to complete the clinical observation as required by the study protocol. 5.Patients with contraindications to acupuncture, such as those who are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Visual Analogue Scale;Hamilton Anxiety Rating Scale;Hamilton Depression Scale;The number of migraine attack;the frequency of migraine attack;the duration of migraine attack;Clinical efficacy rate;

Countries

China

Contacts

Public ContactHailun Jiang

The First Affiliated Hospital of Zhejiang Chinese Medical University

woqumaibocai@163.com18868778977

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026